Table 2.
Characteristic | Diagnosis in 1 year following SR-CXR | Diagnosis in 2 years following SR-CXR |
---|---|---|
Patients, n (%) | 114 (1.3) | 154 (1.7) |
| ||
Mean age, years | 69 | 70 |
| ||
Male, n (%) | 45 (39.5) | 64 (41.6) |
| ||
Smoker/ex-smoker, n (%) | 107 (93.9) | 145 (94.2) |
| ||
SR-CXR result, n (%) | ||
Positive | 86 (75.4) | 97 (63.0) |
Negative | 28 (24.6) | 57 (37.0) |
| ||
Stage at diagnosis, n (%) | ||
Stage I–II | 34 (29.8) | 50 (32.5) |
Stage III–IV | 80 (70.2) | 104 (67.5) |
| ||
Tumour histology, n (%) | ||
Adenocarcinoma | 38 (33.3) | 50 (32.5) |
Squamous cell carcinoma | 31 (27.2) | 41 (26.6) |
Small cell carcinoma | 15 (13.2) | 22 (14.3) |
Non-small cell carcinoma not otherwise stated and large cella | 17 (14.9) | 18 (11.7) |
Unknown | 13 (11.4) | 23 (14.9) |
Non-small cell group carcinoma not otherwise stated and large cell group data have been combined due to data suppression requirements that prevent reporting of identifiable groups of <5. SR-CXR = self-requested chest X-ray.